Correlation Between Protalix Biotherapeutics and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and Hookipa Pharma, you can compare the effects of market volatilities on Protalix Biotherapeutics and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and Hookipa Pharma.
Diversification Opportunities for Protalix Biotherapeutics and Hookipa Pharma
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Protalix and Hookipa is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and Hookipa Pharma
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 0.85 times more return on investment than Hookipa Pharma. However, Protalix Biotherapeutics is 1.18 times less risky than Hookipa Pharma. It trades about 0.03 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.11 per unit of risk. If you would invest 163.00 in Protalix Biotherapeutics on August 27, 2024 and sell it today you would earn a total of 6.00 from holding Protalix Biotherapeutics or generate 3.68% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. Hookipa Pharma
Performance |
| Timeline |
| Protalix Biotherapeutics |
| Hookipa Pharma |
Protalix Biotherapeutics and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and Hookipa Pharma
The main advantage of trading using opposite Protalix Biotherapeutics and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |